BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10730854)

  • 1. Transplantation tolerance and cytokines: is suppressor cell activity mediated by Th2 cells?
    Holán V
    Folia Biol (Praha); 1998; 44(2):37-44. PubMed ID: 10730854
    [No Abstract]   [Full Text] [Related]  

  • 2. Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance.
    Lowry RP; Takeuchi T; Cremisi H; Konieczny B
    Transplant Proc; 1993 Feb; 25(1 Pt 1):324-6. PubMed ID: 8438319
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of suppressor cells and allograft tolerance.
    Brent L; Horsburgh T; Wood PJ
    Transplant Proc; 1980 Sep; 12(3):464-72. PubMed ID: 6452724
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 17-producing T helper cells in alloimmunity.
    Benghiat FS; Charbonnier LM; Vokaer B; De Wilde V; Le Moine A
    Transplant Rev (Orlando); 2009 Jan; 23(1):11-8. PubMed ID: 19027613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifty years of immunological tolerance.
    Baker PJ; Hraba T
    Folia Biol (Praha); 1998; 44(6):189-92. PubMed ID: 10730861
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IL-4 and Th2 responses in allograft rejection and tolerance.
    Tay SS; Plain KM; Bishop GA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):16-22. PubMed ID: 19337141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of suppressor cells in neonatally induced tolerance to transplantable hepatoma 22A].
    Nikonova MF; Maĭskiĭ IN; Pokrovskaia TA; Demeshina IV
    Biull Eksp Biol Med; 1980 Oct; 90(10):464-5. PubMed ID: 6448640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tolerance in the development of eosinophilic gastrointestinal diseases.
    Varshney P; Burks AW
    Immunol Allergy Clin North Am; 2009 Feb; 29(1):179-87, xiii. PubMed ID: 19141353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total lymphoid irradiation: basic and clinical studies in transplantation immunity.
    Strober S
    Prog Clin Biol Res; 1986; 224():251-62. PubMed ID: 2948195
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
    Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
    J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells.
    Lim DG; Joe IY; Park YH; Chang SH; Wee YM; Han DJ; Kim SC
    Transpl Immunol; 2007 Nov; 18(2):94-100. PubMed ID: 18005851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45.
    Bryce PJ; Oyoshi MK; Kawamoto S; Oettgen HC; Tsitsikov EN
    Int Immunol; 2006 Jan; 18(1):101-11. PubMed ID: 16352630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.
    Ryden A; Stechova K; Durilova M; Faresjö M
    Diabetes Metab Res Rev; 2009 May; 25(4):335-43. PubMed ID: 19382103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.